EP2844282
Blöðruhálskirtilstengdir mótefnavakar og ónæmismeðferðáform með bóluefnum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.4.2013EP published:
12.6.2019EP application number:
13729083.9
EP translation filed:
1.7.2019Grant published:
15.7.2019EPO information:
European Patent Register
Max expiry date:
28.4.2033Expiry date:
28.4.2022
Title:
PROSTATE-ASSOCIATED ANTIGENS AND VACCINE-BASED IMMUNOTHERAPY REGIMENS
Timeline
Today
29.4.2013EP application
12.6.2019EP Publication
1.7.2019Translation submitted
15.7.2019Registration published
28.4.2022Expires
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, 10017, New York, NY, US
Inventor
Name:
BINDER, Joseph JohnAddress:
San Diego, CA, US
Name:
CHO, Helen KimAddress:
San Diego, CA, US
Name:
DERMYER, Michael RobertAddress:
Carlsbad, CA, US
Name:
JOOSS, Karin UteAddress:
San Diego, CA, US
Name:
PIERCE, Brian GregoryAddress:
Wayland, MA, US
Name:
TAN, Joyce TsiAddress:
Chapel Hill, NC, US
Name:
TSAI, Van ToAddress:
San Diego, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261642844 PDate:
4.5.2012Country:
US
Classification
Categories:
A61K 39/395, A61K 31/404, C07K 14/47, C12N 9/48, C12N 9/64, A61K 9/00, A61K 31/7088, C07K 16/28, C07K 16/30, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 3.2.2020
Expires: 28.4.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 16.3.2021
Expires: 28.4.2022
Payer: Örn Þór slf.